14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

Catabasis Pharmaceuticals Stock Forecast

NASDAQ:CATB BUY SELL

$3.80 (-3.31%)

Volume: 0

Closed: May 19, 2022

Hollow Logo Score: 0.000

Catabasis Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:CATB
$3.80 (-3.31%)

Volume: 0

Closed: May 19, 2022

Score Hollow Logo 0.000

Catabasis Pharmaceuticals Stock Forecast NASDAQ:CATB

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2021-09-02 321.05% Wedbush $16.00 Initiates Coverage On Outperform
2021-08-25 242.11% HC Wainwright & Co. $13.00 Upgrades Neutral Buy
2021-05-12 57.89% Ladenburg Thalmann $6.00 Initiates Coverage On Buy
2021-03-11 31.58% Oppenheimer $5.00 Upgrades Perform Outperform
2020-11-02 -69.74% Wedbush $1.15 Downgrades Outperform Neutral
2020-10-27 - Oppenheimer - Downgrades Outperform Perform
2020-10-27 - HC Wainwright & Co. - Downgrades Buy Neutral
2020-10-01 531.58% HC Wainwright & Co. $24.00 Initiates Coverage On Buy

CATB Stock Trend

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($3.85) are considered to be a "second chance" to get out. According to the fan-theory $1.60 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Data

Date Bottom Mid Top
2022-05-23 $3.81 $4.94 $6.06
2022-05-24 $3.77 $4.90 $6.03
2022-05-25 $3.74 $4.86 $5.99
2022-05-26 $3.70 $4.83 $5.95
2022-05-27 $3.67 $4.79 $5.92
2022-05-31 $3.63 $4.75 $5.88
2022-06-01 $3.59 $4.72 $5.84
2022-06-02 $3.56 $4.68 $5.81
2022-06-03 $3.52 $4.64 $5.77
2022-06-06 $3.48 $4.61 $5.73
2022-06-07 $3.45 $4.57 $5.70
2022-06-08 $3.41 $4.54 $5.66
2022-06-09 $3.37 $4.50 $5.62
2022-06-10 $3.34 $4.46 $5.59
2022-06-13 $3.30 $4.43 $5.55
2022-06-14 $3.26 $4.39 $5.51
2022-06-15 $3.23 $4.35 $5.48
2022-06-16 $3.19 $4.32 $5.44
2022-06-17 $3.15 $4.28 $5.41
2022-06-21 $3.12 $4.24 $5.37
2022-06-22 $3.08 $4.21 $5.33
2022-06-23 $3.05 $4.17 $5.30
2022-06-24 $3.01 $4.13 $5.26
2022-06-27 $2.97 $4.10 $5.22
2022-06-28 $2.94 $4.06 $5.19
2022-06-29 $2.90 $4.02 $5.15
2022-06-30 $2.86 $3.99 $5.11
2022-07-01 $2.83 $3.95 $5.08
2022-07-05 $2.79 $3.92 $5.04
2022-07-06 $2.75 $3.88 $5.00

About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT